How has been the historical performance of Clinitech Lab?

Answer:The historical performance of Clinitech Lab shows a mixed trend in financial metrics over the past three years.

Breakdown:
Clinitech Lab's net sales increased from 6.35 Cr in Mar'23 to 6.40 Cr in Mar'24, and further to 8.23 Cr in Mar'25, indicating a positive growth trajectory. Total operating income followed a similar pattern, reaching 8.23 Cr in Mar'25. However, total expenditure also rose significantly from 4.99 Cr in Mar'23 to 7.40 Cr in Mar'25, leading to a decline in operating profit (PBDIT) from 1.36 Cr in Mar'23 to 1.06 Cr in Mar'25. Profit before tax showed a decrease from 0.86 Cr in Mar'23 to 0.55 Cr in Mar'25, while profit after tax also fell from 0.61 Cr in Mar'23 to 0.39 Cr in Mar'25. Despite these declines, earnings per share (EPS) decreased from 4.07 in Mar'23 to 1.71 in Mar'25. On the balance sheet, total assets grew from 5.88 Cr in Mar'23 to 10.55 Cr in Mar'25, with total liabilities increasing from 5.88 Cr to 10.55 Cr in the same period. The company reported a net cash inflow of 2.00 Cr in Mar'25, contrasting with previous years where cash flow from operating activities was negative. Overall, Clinitech Lab's financial performance reflects growth in sales and assets but challenges in profitability and cash flow management.